The latest news, updates and opinions on Shire from the expert team here at MoneyWeek
Shire: a tempting buy-out bet
Features Pharmaceuticals firm Shire is set to be taken over – but it’s cheap even if the deal fails.
If you’d invested in: Dechra Pharmaceuticals and Shire
Features Dechra Pharmaceuticals is a drugs company that specialises in the development of medical treatments for pets. Over the next three years, the firm’s earnings per share is expected to more than double.
By Alice Gråhns PublishedFeatures
Three stocks to profit from the boom in pharma M&A
Opinion Ailsa Craig picks three stocks that should capitalise on the M&A trend in the pharmaceutical sector, either as potential targets or as well-established acquirers of other rivals.
By Ailsa Craig PublishedOpinion
Pocket some grey pounds – three healthcare stocks to buy now
Opinion The ageing population is an opportunity for the health and medical sector. Here, professional investor Garry White picks three healthcare stocks to buy now.
By Garry White PublishedOpinion
UK stocks ahead as investor shrug off fresh oil price drop
Market Reports Investors have shrugged off concerns over the falling price of oil this morning ahead of the release of US earnings data.
By Kam Patel PublishedMarket Reports
The rise of ‘tax inversion’
Features More and more American businesses are snapping up companies in low-tax countries to make that their official home. British companies are in their sights. Simon Wilson reports.
By Simon Wilson PublishedFeatures